BDTB · Bodhi Tree Biotechnology Inc
The latest filing states the doubt was alleviated.
“Near-term liquidity constraints, including recurring operating losses and negative cash flows, create conditions that would otherwise raise substantial doubt. ... management determined that substantial doubt regarding the Company's ability to continue as a going concern is alleviated.”View the 10-Q filed Aug 14, 2026
Price & Indicators
The closing range uses available history since Mar 11, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Consulting Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BDTB
this stock
Bodhi Tree Biotechnology Inc
|
$7.17M | — | — | — | — |
|
VRSK
Verisk Analytics, Inc.
|
$25.16B | -14.7% | +6.6% | 29.5 | 3.2% |
|
EFX
Equifax Inc
|
$20.74B | -18.6% | +6.9% | 31.0 | 4.4% |
|
BAH
Booz Allen Hamilton Holding Corp
|
$9.00B | -11.1% | -6.4% | 11.8 | 5.7% |
|
FCN
Fti Consulting, Inc
|
$4.16B | -11.8% | +2.4% | 18.2 | 11.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BDTB | — | — | — | +88.0% | — |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | — | — | — | +87.1% | — |